**Core Concept**
The question requires knowledge of tocolytic agents, which are medications used to delay premature birth. Nifedipine is a calcium channel blocker commonly used as a tocolytic agent. However, when combined with another tocolytic agent, it can lead to a dangerous interaction.

**Why the Correct Answer is Right**
Magsulf, also known as magnesium sulfate, is a potent tocolytic agent that works by blocking calcium channels and reducing uterine contractions. When combined with nifedipine, another calcium channel blocker, the risk of severe neuromuscular blockade increases. This is because both medications can cause a significant decrease in ionized calcium levels, leading to muscle weakness and paralysis. The combination of nifedipine and magnesium sulfate can result in a synergistic effect, amplifying the risk of neuromuscular blockade.

**Why Each Wrong Option is Incorrect**
**Option A:** Terbutaline is a beta-2 adrenergic agonist used as a tocolytic agent, but it does not interact with nifedipine in a way that increases the risk of neuromuscular blockade.

**Option C:** Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that can be used as a tocolytic agent, but it works through a different mechanism and does not interact with nifedipine to cause neuromuscular blockade.

**Option D:** Atosiban is an oxytocin receptor antagonist used as a tocolytic agent, but it does not interact with nifedipine in a way that increases the risk of neuromuscular blockade.

**Clinical Pearl / High-Yield Fact**
When using tocolytic agents, it is essential to monitor patients closely for signs of neuromuscular blockade, such as muscle weakness or paralysis. The combination of nifedipine and magnesium sulfate is a classic example of a potentially hazardous interaction that can lead to severe complications.

**✓ Correct Answer: B. Magsulf**